title: High-fat diets and seizure control in myoclonic-astatic epilepsy: a single center's experience.
abstract: OBJECTIVE
  To determine the efficacy of the Modified Atkins Diet (MAD) and Ketogenic Diet (KD) in seizure control within a population of myoclonic-astatic epilepsy (MAE) patients.
  
  
  METHODS
  This was a retrospective, single center study evaluating the seizure control by high fat diets. Seizure diaries kept by the parents performed seizure counts. All patients met the clinical criteria for MAE.
  
  
  RESULTS
  Nine patients met the clinical criteria. We found that both the MAD and KD were efficacious in complete seizure control and allowed other medications to be stopped in seven patients. Two patients had greater than 90% seizure control without medications, one on the KD and the other on the MAD. Seizure freedom has ranged from 13 to 36 months, and during this time four patients have been fully weaned off of diet management. One patient was found to have a mutation in SLC2A1.
  
  
  CONCLUSIONS
  Our results suggest that strictly defined MAE patients respond to the MAD with prolonged seizure control. Some patients may require the KD for seizure freedom, suggesting a common pathway of increased requirement for fats. Once controlled, those fully responsive to the Diet(s) could be weaned off traditional seizure medications and in many, subsequently off the MAD or KD.
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Simard-Tremblay
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: Berry
authors.affiliation: Division of Nutrition, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: Aaron
authors.initials: A
authors.lastname: Owens
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
authors.forename: William Byron
authors.initials: WB
authors.lastname: Cook
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
authors.forename: Haley R
authors.initials: HR
authors.lastname: Sittner
authors.affiliation: Division of Nutrition, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: Marta
authors.initials: M
authors.lastname: Mazzanti
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA.
authors.forename: Jennifer
authors.initials: J
authors.lastname: Huber
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA; Department of Psychiatry, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: Molly
authors.initials: M
authors.lastname: Warner
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA; Department of Psychiatry, Seattle Children's Hospital, Seattle, WA, USA.
authors.forename: Hillary
authors.initials: H
authors.lastname: Shurtleff
authors.affiliation: Division Pediatric Neurology, Seattle Children's Hospital/University of Washington, Seattle, WA, USA. Electronic address: russ.saneto@seattlechildrens.org.
authors.forename: Russell P
authors.initials: RP
authors.lastname: Saneto
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use; D002675:Child, Preschool; D050528:Diet, Carbohydrate-Restricted; D059305:Diet, High-Fat; D055423:Diet, Ketogenic; D004831:Epilepsies, Myoclonic / Q000178:diet therapy* / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D012189:Retrospective Studies; D012640:Seizures / Q000178:diet therapy* / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants
keywords: Doose syndrome; Ketogenic Diet; Modified Atkins Diet; Myoclonic-atonic seizures; SLC2A1